No Data
No Data
10-K: Annual report
Express News | Zura Bio FY2024 GAAP EPS Of $(0.60) Vs. $(2.09) YoY, Cash And Cash Equivalents Were $176.5M As Of December 31, 2024, Expected To Provide Cash Runway Through 2027
Zura Bio 2024 Loss/Shr 60c >ZURA
Zura Bio 2024 Loss $45.4M >ZURA
Zura Bio: Cash Runway Anticipated Through 2027 >ZURA
Press Release: Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates